This inventor holds 3 USPTO granted patents. Top assignees: Jetema Co., Ltd., Procell Therapeutics Inc.. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2025
Title: MinJoong Kim: Innovator in Botulinum Toxin Production
Introduction
MinJoong Kim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of botulinum toxin. With a total of 3 patents, his work focuses on improving the efficiency and safety of toxin production processes.
Latest Patents
One of his latest patents involves a medium composition for botulinum toxin production. This innovative medium comprises potato peptone, yeast extract, and glucose. It is designed to exclude animal-derived products and major allergens. This formulation allows the botulinum toxin-producing strain to achieve maximum growth levels in a shorter time frame. As a result, it effectively shortens production time and reduces costs associated with botulinum toxin production.
Career Highlights
Throughout his career, MinJoong Kim has worked with reputable companies such as Jetema Co., Ltd. and Procell Therapeutics Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and toxin production.
Collaborations
MinJoong Kim has collaborated with several professionals in his field, including Jae Young Kim and Jeong Sun Nam. These collaborations have further enhanced his research and development efforts.
Conclusion
MinJoong Kim's innovative work in botulinum toxin production showcases his commitment to advancing biotechnology. His patents reflect a dedication to improving production processes while ensuring safety and efficiency.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile